Clinical trial Recruiting at 1 site Interventional Ages 65 to 89

See if three months of visual flicker at 16.67 Hz helps cognition and mood in older adults with or without subjective cognitive concerns

Official title: High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive Decline

Run by University of Florida · NCT07395609 · Data updated 2026-11-12

This study tests whether three months of flicker stimulation three times a week can improve thinking, movement, and mood in healthy older adults and those with subjective cognitive decline.

More Subjective Cognitive Decline (SCD) trials

Quick facts

Study typeInterventional
Ages65 Years to 89 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedAugust 14, 2026
Main results expectedOctober 31, 2028
Study endsOctober 31, 2028
Registry record updatedSeptember 23, 2026
Trial IDNCT07395609 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Community-dwelling adults aged 65–89 who can walk unassisted and speak English, including those with subjective cognitive decline and a family history of dementia.

Probably not a fit

Individuals who do not respond to the flicker intervention or who have underlying conditions affecting brain health may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare a high-frequency visual flicker intervention (16.67 Hz) to a low-frequency control (1 Hz) over 12 weeks in adults aged 65–89 living at home. The goal is to see if the flicker helps cognition, mobility, and mood and whether it slows brain aging markers and changes in biomarkers related to Alzheimer's disease. The study will monitor brain structure and functional networks, along with blood biomarkers, to understand any biological effects. Participants may be drawn from those with and without subjective cognitive decline and will be assessed at baseline and after the intervention. The design is interventional but does not specify a traditional randomization scheme in the provided information.

Why it matters

Potential benefit: If successful, participants could experience improved cognition or mood and researchers may uncover signals suggesting slowed brain aging.

How similar studies have gone: Prior work in noninvasive sensory stimulation has shown potential cognitive and brain network effects in aging and dementia, but results vary and this approach remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Community dwelling men and women 65-89 years old
* Ability to walk unassisted for 10 min
* English speaking Additional Inclusion Criteria for SCD
* No evidence of dementia or MCI based on cognitive screening (i.e., Montreal Cognitive Assessment (MoCA) score within normal limits for age, education, and sex using the NACC Uniform Data Set (UDS) norms
* Global Clinic Dementia Rating (CDR) score must be 0 or 0.531
* Subjective report of cognitive complaints with scores \>20 on the Cognitive Change Index (CCI-20), a validated scale of subjective cognitive decline6; this scale consists of 20 items that are rated on a 5-point Likert scale, where 1= "Normal: No change compared to 5 years ago", 3= "Mild Problem: Some change compared to 5 years ago) and 5="Severe Problem: Much worse compared to 5 years ago"
* Family history of dementia/probable AD in first degree relative (parents, children, siblings)
* Normal functional behavior in terms of daily activities, based on the Functional Activities Scale In line with recommendations of the SCD task force an informant must be available for two reasons: a) to provide information about the participant's cognition using the informant version of the CDR and CCI-20, and b) to corroborate normal IADL's on the Functional Activity Questionnaire (informant data will be collected via a phone call and linked by code with the participant data).

Exclusion criteria

* If participants score less than 21 on the Telephone Interview for Cognitive Status (TICS)
* Significant medical event requiring hospitalization in the past 6 months that has the potential to contaminate data being collected (fracture, hospitalization etc.)
* Severe visual impairment or corrected visual acuity less than 20/40 (as per self-report), which would preclude completion of assessments
* Inability to undergo MRI brain imaging due to claustrophobia or implants such as pacemakers, heart valves, brain aneurysm clips, orthodontics, certain non-removable body jewelry, or shrapnel containing ferromagnetic metal
* History of severe stroke
* Epilepsy or family history of epilepsy, past seizure history, as well as history of migraines
* Current use of psychotropic medications
* Any major ADL disability (unable to feed, dress, bath, use the toilet, or transfer)
* Report of lower extremity pain due to osteoarthritis that significantly limits mobility
* Diagnosis or treatment for rheumatoid arthritis
* Known neuromuscular disorder or overt neurological disease (e.g., Multiple Sclerosis, Rhabdomyolysis, Myasthenia Gravis, Ataxia, Apraxia, post-polio syndrome, mitochondrial myopathy, Parkinson's Disease, ALS etc.)
* Unable to communicate because of severe hearing loss or speech disorder
* Planned surgical procedure or hospitalization in the next 4 months (joint replacement, coronary artery bypass graft, etc.)
* Severe pulmonary disease, requiring the use of supplemental oxygen
* Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, recent history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
* Use of walker or wheelchair

Where it's running

  • University of Florida
    Gainesville, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.